Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |